## VRT: Vertiv Holdings Co - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 0.86 indicates fundamental undervaluation. Quality metrics strong (ROE 39%, ROA 11%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($158.16)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($1.05M) |
| Sells | 3 ($0.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (+2.2%)
- Blackrock Inc.: 9.4% (+2.4%)
- Bank of America Corp: 2.5% (-6.2%)
- State Street Corpora: 2.2% (+2.3%)
- JPMORGAN CHASE & CO: 2.2% (+101.7%)

### Key Risks

1. High beta (2.03) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +3.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.86 indicates undervaluation relative to growth. Quality metrics strong (ROE 39%, ROA 11%). Revenue growth strong at 20% YoY. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $64.1B |
| Beta | 2.03 |
| 52W Range | $53.60 - $202.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.86 |
| Forward P/E | 33.9 |
| Current P/E | 43.3 |
| YoY Growth | 27.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -2.8% to 1.0% (+3.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.0pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.85), confirming momentum. RSI neutral at 54. OFD pattern: -DLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.00% (CS: 61) | Neutral |
| RSI_14 | 54.1 | Neutral |
| MACD Histogram | 0.85 | Bullish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.037x | Above |
| vs SMA200 | 1.429x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $178.88
- **Stop Loss:** $158.16 (11.6% risk)
- **Target:** $220.32 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 45
- **Position Value:** $8,049.60
- **Portfolio %:** 8.05%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-11 (Est: $1.29)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.99 | $1.24 | +25.0% |
| 2025Q2 | $0.83 | $0.95 | +14.4% |
| 2025Q1 | $0.62 | $0.64 | +3.9% |
| 2024Q4 | $0.82 | $0.99 | +20.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*